GILD Message Board Post 10936812 | Gilead Sciences Inc.
home / stock / gild / gild message board
Ultimate
(investorshangout)
Posted on: Jul/20/2020 14:40:53
Source: investorshangout
https://investorshangout.com/post/view?id=5832110
Ultimate: Looks like Remdesivir could benefit from a Brilacidin combination. http://www.ipharminc.com/press
News, Short Squeeze, Breakout and More Instantly...
-
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2024 financial results and guidance will be released on Thursday, August 8, 2024, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’...
-
– New 5-Year Clinical and Real-World Data Reinforce Biktarvy ® as a Long-Term Treatment Option for a Diverse Range of People with HIV, Including Those with Comorbidities – – Investigational, Once-Daily, Once-Weekly and Twice-Yearly Dosing Frequenc...
-
– PURPOSE 1 Data Showed Zero Infections and 100% Efficacy and Superiority of Lenacapavir to Background HIV Incidence and Daily Truvada ® for PrEP – – If Approved, Lenacapavir Would be the First and Only Twice-Yearly PrEP Choice and Could Address C...